Lake Street Capital Cuts ReWalk Robotics (NASDAQ:LFWD) Price Target to $4.50

ReWalk Robotics (NASDAQ:LFWD) had its price objective reduced by equities researchers at Lake Street Capital from $6.00 to $4.50 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Lake Street Capital’s price objective suggests a potential upside of 145.23% from the stock’s current price.

LFWD has been the topic of a number of other research reports. Laidlaw initiated coverage on shares of ReWalk Robotics in a research report on Monday, February 10th. They set a “buy” rating and a $10.00 price target on the stock. HC Wainwright reissued a “buy” rating and set a $13.00 price objective on shares of ReWalk Robotics in a research report on Thursday.

ReWalk Robotics Price Performance

NASDAQ LFWD traded down $0.01 on Thursday, reaching $1.84. The company had a trading volume of 337,060 shares, compared to its average volume of 1,333,604. The firm has a market cap of $19.51 million, a price-to-earnings ratio of -0.74 and a beta of 2.05. ReWalk Robotics has a fifty-two week low of $1.25 and a fifty-two week high of $7.70. The business has a 50 day moving average of $1.74 and a two-hundred day moving average of $2.42.

Insider Transactions at ReWalk Robotics

In other news, Director Michael Swinford purchased 21,622 shares of the business’s stock in a transaction on Monday, November 25th. The stock was purchased at an average cost of $2.03 per share, with a total value of $43,892.66. Following the acquisition, the director now directly owns 65,040 shares in the company, valued at approximately $132,031.20. This trade represents a 49.80 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Global Fund Lp Lind II sold 381,676 shares of the firm’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the completion of the transaction, the insider now directly owns 1,049,430 shares of the company’s stock, valued at approximately $3,526,084.80. The trade was a 26.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders purchased a total of 44,529 shares of company stock worth $84,972 in the last quarter. Insiders own 2.50% of the company’s stock.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.